Does Retention and Remission Rates to 2nd and 3rd TNF Inhibitors in Patients with Axial Spondyloarthritis Depend on the Reason from Withdrawal to the Previous Treatment? – Real World Data from 12 European Countries in the EuroSpA Research Collaboration

Lykke Midtbøll Ørnbjerg, Cecilie Cornelia Heegaard Brahe, A. G. Loft, J. Askling, A. Ciurea, H. Mann, S. Akar, E. Kristianslund, D. Nordström, M. J. Santos, C. Codreanu, M. Pombo-Suarez, Z. Rotar, B. Gudbjornsson, D. DiGuiseppe, M. J. Nissen, K. Pavelka, S. Senel, J. Sexton, K. K. EklundA. Barcelos, R. Ionescu, C. Sánchez-Piedra, M. Tomsic, A. J. Geirsson, I. van der Horst-Bruinsma, G. Macfarlane, F. Iannone, Brigitte Michelsen, Lise Hejl Hyldstrup, N. S. Krogh, Merete Lund Hetland, Mikkel Østergaard

Original languageEnglish
Article number1551
JournalArthritis & Rheumatology
Volume71
Issue numberS10
Number of pages4
ISSN1537-2960
Publication statusPublished - 2019

Cite this